Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israel, Tel Aviv
Ofer Merimsky
41 years of experience
accreditations :
Clinic is certified :
Radiotherapy for prostate cancer in Israel costs from $22,000 to $39,000 on average. Final pricing depends on the radiation technology, session count, and clinic type. Patients save approximately 37% compared to the US, where the average cost is $35,000. Packages typically include oncologist consultations, CT-based simulation, treatment planning, and all radiation sessions.
Bookimed Expert Insight: Choosing a large center like Sourasky (Ichilov) provides access to multidisciplinary tumor boards. They offer a 90% oncology success rate and JCI-accredited safety standards. While Assuta packages start around $8,800, Sourasky typically runs about $11,600 to $29,100. This higher range reflects their status as a top-10 global medical destination. Patients benefit from specialists like Dr. Ofer Merimsky, who trained at New York Hospital. This blend of US-level expertise and lower Israeli pricing offers high clinical value.
Why choose Israel for radiotherapy for prostate cancer?
Access advanced Radiotherapy for prostate cancer solutions in trusted clinics .
| Israel | Turkey | Austria | |
| Radiotherapy for prostate cancer | from $22,000 | from $4,000 | from $14,000 |
Day 1
Day 2
Day 3
Week 1
Week 2 - Week 7
Week 8
Week 9 - Week 12
Week 13
Please note that individual experiences may vary, and the above timeline is a general guide. Always consult your doctor for personalized advice.
As the leading global medical tourism platform, Bookimed.com takes great responsibility for providing accurate and reliable information to our clients, including patients and medical centers, about Radiotherapy for prostate cancer in Israel. All the information provided on Bookimed.com is grounded in research, foresight, and expertise and meets high interest related to the product and follows:
We form our listings of clinics and doctors in Israel who offer Radiotherapy for prostate cancer with strict regulations of our smart automatic ranking system. The system is based on real Bookimed patient rates to provide the most objective and transparent information about clinics and medical services there.
Our experienced data scientist collects data daily, monitors, and optimizes the ranking system using machine learning and artificial intelligence to ensure that the ranking system is up-to-date and provides accurate results.
We collect the opinions of Bookimed clients only after getting medical experience with the clinic in Israel that provides Radiotherapy for prostate cancer — so everyone on the platform can trust the facility they choose. We strive to make the content on our platform as useful as possible and ensure the freedom to express critical opinions. Thus, we publish positive and negative reviews, aiming at being a source for informed decision-making for our future clients.
On Bookimed.com, you may find choice and convenience to find the best medical solutions from top medical services providers in Israel who offer Radiotherapy for prostate cancer just in one place, and often at competitive prices. Making sure to deliver the freshest information, the clinic’s representatives update doctors’ CVs, clinics’ capacities, before-after pictures, prices, packages, and specials by themselves shortly. You may meet the clinic’s representative and check the date of updated content at every clinic’s page to make sure of its trustworthiness.
Our blog and supportive pieces are created by professional authors with at least 3-year experience in medical writing and edited by medical specialists with relevant clinical and research expertise — all carefully recruited to the team. We strive to enhance patient access to health information, making it expert but easy to understand. All pieces follow the Bookimed’s Editorial Guidelines.
We are made of people and for people — and that"s our core value. That"s why all the data presented on the platform is collected, edited, reviewed, and updated regularly by our patients, our partner clinics in Israel, and our team, including the Bookimed Medical Advisory Board, which consists of the world-renowned doctors with value expertise over 20 years of practice, and a positive reputation. Learn more about us and our mission.
In case you find any mistake or have any questions on the information presented on Bookimed.com about Radiotherapy for prostate cancer in Israel, please feel free to contact us at marketing@bookimed.com.
Prof. Merimsky leads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center, specializing in complex radiotherapy cases.
Dr. Sarid specializes in radiotherapy for prostate cancer at Sourasky Medical Center, with over 38 years of experience of focused oncology experience.
Dr. Nir Kleinmann directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is a pioneer in kidney-sparing laser surgery for complex tumors. Forbes and ResultMed named him among Israel’s Best Doctors for 2025 and 2026. Dr. Kleinmann uses a unique dual-laser system to preserve organ function during cancer treatment.
Dr. Yaacov Lawrence is the Chair of Radiation Oncology at Sheba Medical Center. He specializes in precision radiation therapy and neuro-oncology. Dr. Lawrence pioneered celiac plexus radiosurgery for pancreatic cancer pain management. He holds the FASTRO designation, one of the highest honors in his specialty.
This procedure uses radiation to target and destroy cancer cells in the prostate gland.
Radiation for prostate cancer causes fatigue, urinary urgency, and bowel changes like diarrhea or rectal irritation. Most acute symptoms peak late in treatment and improve within 6–8 weeks. Long-term effects, including erectile dysfunction or urinary narrowing, may develop months or years later.
Bookimed Expert Insight: While many focus on fatigue, temporary lactose intolerance is a frequent but overlooked side effect. Data shows patients often experience digestive discomfort triggered by dairy during treatment. Choosing IMRT at centers like Sourasky Medical Center (Ichilov) may result in milder symptoms than SBRT.
Patient Consensus: Patients emphasize that fatigue hits hardest during the second week. Many recommend discussing medications like Flowmax early to manage urinary frequency and setting realistic expectations for long-term sexual health.
Radiation therapy for localized prostate cancer in Israel achieves a 10-year survival rate of 90% to 98%. Advanced protocols like Stereotactic Body Radiation Therapy (SBRT) report a 98.6% success rate in controlling cancer over 5 years. Results remain comparable to surgical outcomes while offering non-invasive alternatives.
Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center maintain a 90% average success rate across all cancer cases. This high benchmark is driven by doctors like Professor Yaacov Lawrence, who holds a rare Fellowship from the American Society for Radiation Oncology. Patients often choose Israel for SBRT protocols that reduce treatment time from months to just 5 days without compromising survival.
Patient Consensus: Patients report that radiation offers a smoother recovery than surgery. While many appreciate the high long-term survival statistics, they emphasize discussing potential side effects like erectile dysfunction early.
Israel offers advanced radiation therapies for prostate cancer including Stereotactic Body Radiation Therapy (SBRT), CyberKnife, and LDR/HDR Brachytherapy. Leading Joint Commission International-accredited centers like Sourasky and Assuta utilize high-precision technologies including Novalis TrueBeam STx and MR-Linac to achieve oncology success rates exceeding 90%.
Bookimed Expert Insight: Sourasky Medical Center serves 40,000 cancer patients annually, creating a massive data pool for personalized protocols. Their oncologists often recommend VMAT over standard IMRT because it reduces treatment sessions from 40 down to approximately 20 to 28 visits.
Patient Consensus: Patients often prioritize SBRT and CyberKnife options to reduce side effects and allow for a faster return to daily activities. Many emphasize confirming machine availability like MR-Linac during initial consultations for the most precise targeting possible.
Prostate cancer recurrence post-radiation is usually identified via biochemical recurrence when PSA levels rise by 2 ng/mL above the lowest recorded level. Treatment planning involves PSMA PET scans to differentiate between localized recurrence and metastatic spread, guiding decisions on salvage therapies or hormonal control.
Bookimed Expert Insight: While many assume surgery is the next step, our data shows Israeli oncologists often favor precision salvage brachytherapy or CyberKnife. Surgeons like Prof. Ofer Merimsky at Sourasky Medical Center (Ichilov) utilize these advanced technologies because they minimize damage to tissues already scarred by previous radiation.
Patient Consensus: Many patients emphasize not panicking over a minor PSA bounce, which is common 12–24 months post-treatment. They recommend mpMRI and biopsy to confirm local lesions before committing to more invasive salvage surgery.
Brachytherapy is widely available in Israel for prostate cancer at Joint Commission International-accredited centers in Tel Aviv and Ramat Gan. Surgeons use internal radiation for localized stage T1 or T2 cases. Leading oncologists offer both Low-Dose Rate and High-Dose Rate techniques to preserve surrounding tissue.
Bookimed Expert Insight: While many countries focus on external beam therapy, Israeli centers like Sourasky integrate brachytherapy with genetic testing tools like Foundation One. This helps doctors select internal radiation more precisely. Patients often find specialized expertise under leaders like Dr. Yaacov Lawrence at Sheba Medical Center.
Patient Consensus: Patients emphasize verify availability directly since specialized internal radiation is less common than external beam options. Many note that monitoring PSA levels for up to 36 months is essential for tracking long-term success.
Radiation therapy for prostate cancer in Israel generally lasts 1 to 8 weeks, depending on the chosen protocol and cancer stage. Modern techniques like SBRT require only 5 sessions over 2 weeks, while traditional protocols may involve daily sessions Monday through Friday for up to 8 weeks.
Bookimed Expert Insight: While traditional radiation takes 8 weeks, JCI-accredited clinics like Assuta and Sourasky use Novalis TrueBeam STx technology. This precision equipment allows doctors like Yaacov Lawrence to offer ultra-hypofractionated SBRT. This approach cuts visits from 37 down to 5 without compromising effectiveness or safety.
Patient Consensus: Many patients appreciate internal radiation or SBRT to significantly shorten their stay in Israel. Most recommend confirming if hypofractionated protocols are suitable for your specific case before traveling.
Doctors determine radiation success by monitoring Prostate-Specific Antigen levels. They track the nadir, which is the lowest PSA value reached after treatment. Unlike surgery, radiation levels drop gradually over 6 to 24 months, generally settling between 0.2 and 0.5 ng/mL.
Bookimed Expert Insight: While patients expect a quick drop, our data shows Israeli centers like Sourasky often utilize the Novalis TrueBeam STx to achieve precise targeting that minimizes healthy tissue damage. This precision means a PSA bounce—a temporary rise 12 to 24 months post-treatment—is common and rarely indicates treatment failure.
Patient Consensus: Many patients find it helpful to focus on the long-term downward trend of their PSA results. They recommend asking your team for your specific nadir threshold to avoid anxiety during minor fluctuations.